Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma (2015)
- Authors:
- USP affiliated authors: MARIE, SUELY KAZUE NAGAHASHI - FM ; SHINJO, SUELI MIEKO OBA - FM ; IZUMI, CLARICE - FMRP ; ROSA, JOSE CESAR - FMRP
- Unidades: FM; FMRP
- DOI: 10.1186/s12885-015-1473-9
- Subjects: GLIOMA; NEOPLASIAS CEREBRAIS; SISTEMA NERVOSO CENTRAL; PROTEÍNAS (ESTUDO)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: BMC Cancer
- ISSN: 1471-2407
- Volume/Número/Paginação/Ano: v. 15, n. 481, p. (online), 2015
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
GIMENEZ, Marcela et al. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma. BMC Cancer, v. 15, n. 481, p. (online), 2015Tradução . . Disponível em: https://doi.org/10.1186/s12885-015-1473-9. Acesso em: 23 abr. 2024. -
APA
Gimenez, M., Marie, S. K., Oba-Shinjo, S., Uno, M., Izumi, C., Oliveira, J. B., & Rosa, J. C. (2015). Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma. BMC Cancer, 15( 481), (online). doi:10.1186/s12885-015-1473-9 -
NLM
Gimenez M, Marie SK, Oba-Shinjo S, Uno M, Izumi C, Oliveira JB, Rosa JC. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma [Internet]. BMC Cancer. 2015 ; 15( 481): (online).[citado 2024 abr. 23 ] Available from: https://doi.org/10.1186/s12885-015-1473-9 -
Vancouver
Gimenez M, Marie SK, Oba-Shinjo S, Uno M, Izumi C, Oliveira JB, Rosa JC. Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma [Internet]. BMC Cancer. 2015 ; 15( 481): (online).[citado 2024 abr. 23 ] Available from: https://doi.org/10.1186/s12885-015-1473-9 - Quantitative proteomics analysis of heat shock proteins involved in unfoldeld protein response in glioblastoma cell lines induced by different drugs
- Quantitative proteomics of GBM derived cell line U87MG silenced by SI-RNA-nucleophosmin using iTRAQ
- Evaluation of proliferation and migration of T98G and U87MG cells under EGF stimulus
- Changes in the expression of proteins associated with aerobic glycolysis and cell migration are involved in tumorigenic ability of two glioma cell lines
- Clinical proteomics in cancer: a short cut between genome mutation and glioma development
- Correlation of nucleophosmin, CRMP2 and RKIP with tumor progression in astrocytomas
- Quantitative proteomic analysis and functional studies reveal that nucleophosmin is involved in cell death in glioblastoma cell line transfected with siRNA
- Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas
- Quantitative proteomic analysis reveals a molecular triad signature as biomarker candidates for astrocytomas and oligodendrogliomas
- Mass spectrometry-based proteomics to study glioblastoma short and long survival and oligodendrogliomas grade II and III
Informações sobre o DOI: 10.1186/s12885-015-1473-9 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
